Liu, Yusi. 2024. “How Do Varying Concentrations and Treatment Durations of Anti-PDL1 Antibodies Affect HCT116 Cell Viability, Xenograft Tumor Size, and T Cell Activation, As Measured by MTT Assay, Tumor Weight, and IL-2 Production, Respectively?”. MedScien 2 (6):2912. https://doi.org/10.61173/n49rc157.